A message, a messenger, and someone to do the work. This California consulting collective puts all three on the same assignment - with a $5,000 leadership cohort that makes its approach unusually tangible.
In a market built on specialization, Norwest sells breadth: one global fund, checks from $1 million to $200 million, and an operator bench designed to show up only when invited.
Felicis built a $4.1 billion venture platform around an unusual wager: founders perform better when their investors fund the human being, surrender a little control and show up before the outcome looks inevitable.
jo is a voice-first personal AI agent for macOS that runs on your Mac and a private, per-user cloud machine. Rather than waiting to be asked, it proactively summarizes what is on your screen, drafts emails, manages your calendar, clips relevant content, and keeps up with the loose ends of work and life. Built natively in Swift for Apple Silicon and backed by Y Combinator (W24), jo reaches users across Mac, web, iMessage, Telegram, and WhatsApp while keeping personal data local and out of model training.
Hatch is a Menlo Park sleep-technology company that designs bedside devices and a companion content subscription to help people fall asleep and wake up better. Founded in 2014 by former BabyCenter executives Ann Crady Weiss and Dave Weiss, it started with connected products for babies and toddlers (Hatch Rest) before expanding to adults with the Hatch Restore line of sunrise alarm clocks and sound machines. The company pairs hardware with the Hatch Sleep app and the paid Hatch+ library of sleep sounds, sleep stories, meditations and light-based wind-down routines, reaching more than half a million families.
Apreo Health is a clinical-stage medical device company in Menlo Park, California developing the BREATHE Airway Scaffold, a bronchoscopically delivered, self-expanding nitinol implant that relieves lung hyperinflation in patients with severe emphysema. Unlike existing valve and surgical treatments that collapse or remove lung tissue, the scaffold gently tents open damaged airways to release trapped air while sparing healthy tissue, aiming to expand who can be treated. The company raised a $130M Series B in August 2025 to run its pivotal BREATHE-3 trial and prepare for early commercialization.
Bedrock Data is a Menlo Park, California data security company that builds an AI-native data security posture management (DSPM) platform. Its Metadata Lake technology discovers, classifies and tracks sensitive data across cloud, SaaS and AI systems at petabyte scale, giving enterprises visibility into what data they have, who can access it and how it moves - without copying that data out of a customer's environment.
Inquis Medical is a Silicon Valley medical device company founded in 2020 by serial medtech entrepreneurs Vahid and Mojgan Saadat. Its flagship AVENTUS Precision Thrombectomy System removes blood clots from patients with pulmonary embolism (PE) and deep vein thrombosis (DVT), using proprietary TrueClot tissue-sensing technology that gives physicians real-time feedback to distinguish blood, clot, and vessel wall while minimizing blood loss through autologous blood reinfusion. Backed by $115M in total funding including a $75M Series C in January 2026, the company is scaling nationwide commercial adoption after winning FDA 510(k) clearance for PE in 2025.
KonaWare was a Menlo Park mobility-software company founded in 1999 that built a platform and development tools for putting mission-critical enterprise applications into the hands of mobile field workers. Its suites covered transportation, logistics and field service - dispatch, proof-of-delivery, electronic driver logs, vehicle inspections and asset tracking - and were engineered to keep data intact whether devices were connected or not, running across laptops, PDAs and early smartphones. Backed by Draper Richards and Western Technology Investment, the company was an early bet on enterprise mobility years before the smartphone made it mainstream; its field-service assets were acquired by ServicePower in 2008.
MyBackHub, built by NSite Medical (legally Nsite, Inc.), is an AI-powered digital health platform for non-operative back and spine care. Spun out of the founders' earlier scoliosis work at the National Scoliosis Clinic, it uses a smartphone-based, radiation-free AI scan (the PostureBackNeck Assessment) to analyze posture and spinal alignment at home, then builds a personalized recovery plan combining adaptive exercises, live Pilates classes, licensed physical therapists, Stanford's Empowered Relief pain program, and a 24/7 AI companion. The company holds FDA 510(k) clearance for its AI-based scoliosis scanning app and delivers care at little to no cost through select Medicare and insurance plans.
Nuvig Therapeutics is a clinical-stage biotech in the San Francisco Bay Area developing next-generation immune modulators for chronic autoimmune and inflammatory diseases. Founded in 2022 on research from The Rockefeller University, its lead candidate NVG-2089 is a first-in-class recombinant Fc fragment that engages type II Fc receptors to recapitulate the anti-inflammatory benefits of IVIg without immunosuppression or the supply constraints of plasma-derived products. The company raised a $161M Series B in December 2024 to push NVG-2089 into Phase 2 for CIDP and other indications.
OLarry is an AI-powered, year-round tax firm built for high-net-worth individuals, founders, and businesses. It pairs certified public accountants with proprietary AI that handles document collection, data classification, and extraction, so its CPAs can focus on proactive, strategic tax planning rather than paperwork. Sold as a flat annual membership, OLarry aims to bring the kind of always-on tax advice once reserved for the ultra-wealthy to thousands of clients across the United States.
Vijil is a Menlo Park-based AI company building trust infrastructure for enterprise AI agents. Founded in 2023 by senior AWS leaders, its modular platform tests, defends, and continuously hardens agents so they are verifiably reliable, secure, and safe - cutting the time it takes enterprises to trust an agent from about six months to six weeks. Vijil raised $17 million in 2025 (total $23 million) and was named a Gartner Cool Vendor.
SolidCore.ai is a Menlo Park cybersecurity startup building the security and governance layer for enterprise generative AI. Founded in 2024 by HyTrust veteran Eric Chiu and former Microsoft security architect Hemma Prafullchandra, its platform captures an immutable record of every LLM prompt, response, and configuration inside a customer's own cloud, then continuously monitors for misconfigurations, policy violations, and risky usage while generating audit-ready evidence for frameworks like NIST AI RMF, ISO 42001, and the EU AI Act. The company emerged from stealth in September 2025 with $4M in seed funding led by Runtime Ventures.
Verantos is a Menlo Park healthcare technology company that turns messy, fragmented patient records - including the clinical notes most platforms ignore - into research-grade real-world evidence (RWE) at scale. Using AI applied to the complete patient record and a rigorous focus on measured accuracy, completeness, and traceability, Verantos helps pharmaceutical companies, regulators, and health systems generate evidence that can hold up to FDA-grade scrutiny across every therapeutic area.
Abram Scientific is a Menlo Park, California medical-device company building CoagCare, a portable point-of-care platform that reads the full blood-coagulation cascade - from clot formation through fibrinolysis - from a single drop of blood in under 10 minutes. By measuring blood viscoelasticity and density on single-use test cards inside a vibration-insensitive handheld meter, CoagCare aims to move coagulation testing out of the central lab and into trauma bays, ambulances, and MEDEVAC helicopters, helping clinicians decide the right transfusion or therapy at the right time.
General Radar Corp. is a Menlo Park deep-tech company building high-resolution, software-defined phased-array (AESA) radar systems for aerospace, defense, wind energy, autonomy, and weather markets. Founded in 2016 by former NASA/JPL engineer Dmitry Turbiner, the company pairs a GaN AESA front-end with digital beam-forming and GPU supercomputing to deliver radars it says are dramatically higher resolution and roughly 20x cheaper than legacy aerospace radar - largely from commercial off-the-shelf parts. It raised a $22M Series A in 2022, bringing total funding to roughly $47.5M.
Hexagon Bio is a Menlo Park biotech that mines the genomes of fungi and other microbes to discover new medicines. Its platform pairs machine learning, genomics, and synthetic biology to read DNA sequences, predict the small molecules they encode, and connect those molecules to the human proteins they act on - skipping the random trial-and-error that has long defined natural-product drug discovery. The company is focused on novel cytotoxic payloads for antibody-drug conjugates (ADCs) in oncology, and in late 2025 extended its approach to agriculture through a joint venture with Corteva.
HiWire is a Silicon Valley advisory firm that helps early-stage startups offload three of the most time-consuming jobs a founder faces: recruiting senior talent, building investor-ready business and product plans, and raising money. Founded by Stanford-trained engineer and longtime recruiter Web Augustine, HiWire offers retained executive search for Director, VP and CEO roles at entrepreneur-friendly fees, contract sourcing, a rapid-turnaround program called SearchXeleration, and hands-on fundraising guidance including introductions to VCs and angel investors.
XOPS (legal name XperiencOps, Inc.) is a Menlo Park-based autonomous IT company that emerged from stealth in August 2025 with $40M co-led by Activant Capital and FPV Ventures. Billed as the first 'Active System of Intelligence,' its platform builds a living knowledge graph of an enterprise's fragmented IT estate and deploys a legion of goal-oriented software robots that coordinate existing systems - ServiceNow, Workday, Okta, Intune - to drive desired states across employee, device, and software lifecycles. The pitch: declare the outcome you want, and XOPS continuously converges your systems toward it, no tickets, no human middleware.
Meta Platforms is the company behind Facebook, Instagram, WhatsApp, Messenger, and Threads - a Family of Apps used by more than 3 billion people daily. Founded as Facebook in 2004 and renamed Meta in 2021, it runs one of the world's largest digital advertising businesses while pouring tens of billions into artificial intelligence (the open-weight Llama models and Meta AI assistant) and wearable computing (Quest headsets and Ray-Ban Meta smart glasses). In 2025 it reported roughly $201 billion in revenue.
Rudolph and Sletten is a California-based general contractor that has built much of Silicon Valley's physical fabric - from Apple Park and Lucasfilm's Skywalker Ranch to hospitals, research labs and university campuses. Founded in 1959 in a Los Altos garage, the firm pioneered guaranteed-maximum-price, fast-track delivery and grew into one of the West Coast's largest builders of technically complex healthcare, life-sciences and education projects. Now a subsidiary of Tutor Perini, it employs roughly 740 people and reports about $307 million in annual revenue.
WelbeHealth is a Menlo Park-based public benefit company operating PACE (Program of All-Inclusive Care for the Elderly) centers across California, delivering comprehensive medical, social, and in-home care that lets frail seniors keep living in their own communities instead of nursing homes.
Antheia is a Menlo Park biotech using engineered yeast to brew the active ingredients behind essential medicines - replacing slow, weather-dependent poppy farming with industrial-scale fermentation. Founded out of Stanford's Smolke Lab, the company aims to end pharmaceutical shortages by turning sugar into complex molecules like thebaine in weeks instead of years.
Orca Bio is a late-stage biotechnology company in Menlo Park, California, building high-precision allogeneic cell therapies. Its proprietary single-cell sorting platform purifies donor immune and stem cells to engineer optimized therapeutic mixtures aimed at curing blood cancers and autoimmune diseases, with its lead candidate Orca-T currently under FDA priority review.